These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29892168)

  • 1. The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome.
    Katsumata R; Shiotani A; Murao T; Ishii M; Fujita M; Matsumoto H; Haruma K
    J Clin Biochem Nutr; 2018 May; 62(3):270-276. PubMed ID: 29892168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1.
    Shiotani A; Kusunoki H; Ishii M; Imamura H; Manabe N; Kamada T; Hata J; Merchant JL; Haruma K
    Neurogastroenterol Motil; 2015 Jan; 27(1):82-91. PubMed ID: 25428414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites.
    Chojnacki C; Medrek-Socha M; Blonska A; Zajdel R; Chojnacki J; Poplawski T
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Moxibustion relieves abdominal hypersensitivity and diarrhea by regulating colonic 5-hydroxytryptamine signaling pathway in rats with diarrhea type irritable bowel syndrome].
    Tong L; Wu LB; Li N; Cheng HL; Cai RL; Chu HR
    Zhen Ci Yan Jiu; 2020 Jul; 45(7):535-40. PubMed ID: 32705826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome.
    Jun S; Kohen R; Cain KC; Jarrett ME; Heitkemper MM
    Neurogastroenterol Motil; 2011 Mar; 23(3):233-9, e116. PubMed ID: 21073637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome.
    Katsumata R; Shiotani A; Murao T; Ishii M; Fujita M; Matsumoto H; Haruma K
    Intern Med; 2017; 56(9):993-999. PubMed ID: 28458330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Zhu SW; Liu ZJ; Sun QH; Duan LP
    Chin Med J (Engl); 2019 Jul; 132(13):1524-1532. PubMed ID: 31205078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea.
    Zhu L; Huang D; Shi L; Liang L; Xu T; Chang M; Chen W; Wu D; Zhang F; Fang X
    Health Qual Life Outcomes; 2015 Apr; 13():49. PubMed ID: 25925746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zhao JM; Lu JH; Yin XJ; Chen XK; Chen YH; Tang WJ; Jin XM; Wu LY; Bao CH; Wu HG; Shi Y
    Chin J Integr Med; 2015 Nov; 21(11):855-65. PubMed ID: 25847778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
    United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
    Smith GD
    J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R; Abbasnezhad A; Amani R; Alipour M
    Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
    Matsueda K; Harasawa S; Hongo M; Hiwatashi N; Sasaki D
    Scand J Gastroenterol; 2008; 43(10):1202-11. PubMed ID: 18618371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
    Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
    J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.